Home Helex

Helex

In operation
Seed Round Financing
Novel Targeted Drug Developer

Basic Information

Helex is a therapeutic company leveraging its proprietary LNP drug delivery and AI-based drug design platform to develop a new class of targeted drugs for hereditary kidney diseases. Helex has a team of world-class scientists and drug developers, operating in ASPIRE BioNEST in New York, USA, and Hyderabad, India, and is supported by Bayer Laboratories in Cambridge.
Helex Inc.
NewYork,NewYork,United States of America
15~50 people
January 01, 2021
contact@helex.bio